A Phase 1 trial of RNDP-001, a dopaminergic progenitor drug product, in idiopathic parkinson’s disease
Grant Award Details
Grant Type:
Grant Number:
CLIN2-19068
Investigator(s):
Award Value:
$8,000,000
Status:
Pre-Active
Grant Application Details
Application Title:
